TOP NEWS Stakeholders task firm on patent right for HIV, hepatitis drugs Stakeholders have demanded an open license for the generic production of HIV and hepatitis C drugs to allow low and middle-income countries access to lifesaving drugs. Guardian Nigeria
Experts reveal how to eliminate viral hepatitis as health threat by 2030 Chukwuma Muanya (Lagos), Nkechi Onyedika-Ugoeze, John Akubo (Abuja), Michael Egbejule (Benin City) and Kehinde Olatunji (Lagos)